These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 29098818)
1. [Advanced progress of main pharmacology activities of triptolide]. Cui J; Chen X; Su JC Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2655-2658. PubMed ID: 29098818 [TBL] [Abstract][Full Text] [Related]
2. Triptolide: progress on research in pharmacodynamics and toxicology. Li XJ; Jiang ZZ; Zhang LY J Ethnopharmacol; 2014 Aug; 155(1):67-79. PubMed ID: 24933225 [TBL] [Abstract][Full Text] [Related]
3. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Qiu D; Kao PN Drugs R D; 2003; 4(1):1-18. PubMed ID: 12568630 [TBL] [Abstract][Full Text] [Related]
4. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Brinker AM; Ma J; Lipsky PE; Raskin I Phytochemistry; 2007 Mar; 68(6):732-66. PubMed ID: 17250858 [TBL] [Abstract][Full Text] [Related]
5. Compatibility with Panax notoginseng and Rehmannia glutinosa Alleviates the Hepatotoxicity and Nephrotoxicity of Tripterygium wilfordii via Modulating the Pharmacokinetics of Triptolide. Zhang Q; Li Y; Liu M; Duan J; Zhou X; Zhu H Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351251 [No Abstract] [Full Text] [Related]
6. [Progress in research on mechanisms of anti-rheumatoid arthritis of triptolide]. Liu CF; Lin N Zhongguo Zhong Yao Za Zhi; 2006 Oct; 31(19):1575-9. PubMed ID: 17165577 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression, targeting, release dynamics and early-warning biomarkers in acute cardiotoxicity induced by triptolide in rats. Wang SR; Chen X; Ling S; Ni RZ; Guo H; Xu JW Biomed Pharmacother; 2019 Mar; 111():1467-1477. PubMed ID: 30841462 [TBL] [Abstract][Full Text] [Related]
8. Triptolide attenuates lipopolysaccharide-induced inflammatory responses in human endothelial cells: involvement of NF-κB pathway. Song C; Wang Y; Cui L; Yan F; Shen S BMC Complement Altern Med; 2019 Aug; 19(1):198. PubMed ID: 31375092 [TBL] [Abstract][Full Text] [Related]
9. Triptolide downregulates Treg cells and the level of IL-10, TGF-β, and VEGF in melanoma-bearing mice. Liu B; Zhang H; Li J; Lu C; Chen G; Zhang G; Lu A; He X Planta Med; 2013 Oct; 79(15):1401-7. PubMed ID: 23975869 [TBL] [Abstract][Full Text] [Related]
10. [Progress in research on triptolide]. Liu MX; Dong J; Yang YJ; Yang XL; Xu HB Zhongguo Zhong Yao Za Zhi; 2005 Feb; 30(3):170-4. PubMed ID: 15719629 [TBL] [Abstract][Full Text] [Related]
11. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of Tripterygium wilfordii Hook F. Zhao X; Liu Z; Ren Z; Wang H; Wang Z; Zhai J; Cao D; Lyu S; Li L; Lang R; He Q Eur J Pharmacol; 2020 Aug; 880():173225. PubMed ID: 32464191 [TBL] [Abstract][Full Text] [Related]
12. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Wang B; Ma L; Tao X; Lipsky PE Arthritis Rheum; 2004 Sep; 50(9):2995-303. PubMed ID: 15457469 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii. Ma J; Dey M; Yang H; Poulev A; Pouleva R; Dorn R; Lipsky PE; Kennelly EJ; Raskin I Phytochemistry; 2007 Apr; 68(8):1172-8. PubMed ID: 17399748 [TBL] [Abstract][Full Text] [Related]
14. Triptolide, a novel diterpenoid triepoxide from Tripterygium wilfordii Hook. f., suppresses the production and gene expression of pro-matrix metalloproteinases 1 and 3 and augments those of tissue inhibitors of metalloproteinases 1 and 2 in human synovial fibroblasts. Lin N; Sato T; Ito A Arthritis Rheum; 2001 Sep; 44(9):2193-200. PubMed ID: 11592385 [TBL] [Abstract][Full Text] [Related]
15. Triptolide and its expanding multiple pharmacological functions. Liu Q Int Immunopharmacol; 2011 Mar; 11(3):377-83. PubMed ID: 21255694 [TBL] [Abstract][Full Text] [Related]
16. [Research progress on anti-tumor effects and mechanisms of triptolide and its combined application]. Shi JF; Luo YY; Li JX; Luo RF; Chen L; Li J; Zhang JM; Fu CM Zhongguo Zhong Yao Za Zhi; 2019 Aug; 44(16):3391-3398. PubMed ID: 31602900 [TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic activity of Tripterygium wilfordii and its terpenoids. He MF; Liu L; Ge W; Shaw PC; Jiang R; Wu LW; But PP J Ethnopharmacol; 2009 Jan; 121(1):61-8. PubMed ID: 18996177 [TBL] [Abstract][Full Text] [Related]
18. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms. Zhou ZL; Yang YX; Ding J; Li YC; Miao ZH Nat Prod Rep; 2012 Apr; 29(4):457-75. PubMed ID: 22270059 [TBL] [Abstract][Full Text] [Related]
19. Triptolide: reflections on two decades of research and prospects for the future. Tong L; Zhao Q; Datan E; Lin GQ; Minn I; Pomper MG; Yu B; Romo D; He QL; Liu JO Nat Prod Rep; 2021 Apr; 38(4):843-860. PubMed ID: 33146205 [TBL] [Abstract][Full Text] [Related]
20. Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. Kusunoki N; Yamazaki R; Kitasato H; Beppu M; Aoki H; Kawai S BMC Pharmacol; 2004 Feb; 4():2. PubMed ID: 15040811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]